Co-Authors
This is a "connection" page, showing publications co-authored by Rafael Cantón and Jesús Rodríguez-Baño.
Connection Strength
0.647
-
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Trans R Soc Trop Med Hyg. 2021 10 01; 115(10):1122-1129.
Score: 0.243
-
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic. J Glob Antimicrob Resist. 2021 06; 25:5-7.
Score: 0.233
-
MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae. J Antimicrob Chemother. 2017 05 01; 72(5):1478-1487.
Score: 0.045
-
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis. 2017 07; 17(7):726-734.
Score: 0.045
-
Escherichia coli: an old friend with new tidings. FEMS Microbiol Rev. 2016 07 01; 40(4):437-463.
Score: 0.042
-
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project. J Antimicrob Chemother. 2016 Feb; 71(2):521-30.
Score: 0.040